3D Bio-Fabricated Tissue Engineering
“ We're at the beginning of a paradigm change in medicine with the promise of being able to facilitate regeneration of parts of the human body, where cells and tissues can be engineered to grow healthy, functional organs to replace diseased ones; new genes can be introduced into the body to combat disease; and adult stem cells can generate replacements for cells that are lost to injury or disease."
Scott Gottlieb, US Food and Drug Administration (FDA) Commissioner
Synthetic Biological Constructs for Bio-Engineering Clinical Solutions
BioRegenex is a regenerative technologies biotech.
From Muscle & Nerve Platforms to 3D Matrix Tissue Constructs for Modelling, Regeneration & Tissue/Electronics Interfacing.
Our 3D additive bio-fabrication & bio-engineering technology enables printing of muscle and nerve for regenerative tissue reconstruction applications in therapeutic, sports medicine, trauma, defence & aging population markets.
We are developing muscle replacement treatments for neuromuscular diseases based on our breakthrough myo-regenerative muscle transplant technology using stem cell & gene correction protocols to create implantable therapeutic myoblasts.
We are pioneering personalized cell mediated regenerative tissue technologies which overcome the major issues associated with immune rejection complications.
Treating disease with a focus on Neuromuscular Dystrophies & Oncology associated Cachexia
BioRegenex was founded by an exceptional team of passionate frontier scientists with decades of deep domain knowledge encompassing neuromuscular & neurological research, cell biology, stem cell technologies, gene editing, biomedical engineering & 3D bio-fabrication.
The company is led by a multi-disciplinary team with a proven track record of translational, commercial & financial performance, guided by a world class international scientific advisory board all brought together under the governance & strategic oversight of a world class board.
BioRegenex's neuromuscular therapeutic programs are driven by one aim and a singular focus ... to improve the lives of the patient communities we serve.
The company works closely with patient advocacy groups, academics, KOL's, research foundations & preeminent scientific advisors to ensure our patient led approach to developing treatments is cutting edge & best in class.